Epstein Secrets

EFTA00848766 Source: Bloomberg Avalanche Bio Drops 14%; Analysts Halve PTs on Wet AMD Update 2015-08-14 12:37:45.493 GMT By Cristin Flanagan (Bloomberg) -- Avalanche Biotech drops 14% in pre-mkt trading after announcing post-mkt yday plans to scrap a planned Phase 2b trial and instead initiate added

ory: EFTA00848767 Cristin Flanagan in New York at +1-212-617-8919 or [email protected] To contact the editors responsible for this story: Arie Shapira at +1-212-617-1488 or ashapira3Pbloomberg.net Cristin Flanagan EFTA00848768

mbardella adds that in second set of negative news, GSM's largest shareholder, Grupo Villar Mir (55% interest in stock), plans to sell 1.9m shares (Bloomberg data says Grupo owns 94.55m shares) * GSM has 5 buys, 0 holds, 0 sells; avg PT $21: Bloomberg data * NOTE: March 23, Ferroglobe Defended at Stifel

ppenheimer After ITC Decision To contact the reporter on this sto Janet Freund in New York at To contact the editors res onsible for this story: Arie Shapira at Richard Richtmyer CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0089113 CONFIDENTIAL SDNY GM_00235297 EFTA01387060

g Avalanche Bio Drops 14%; Analysts Halve PTs on We= AMD Update 2015-08-14 12:37:45.493 GMT By Cristin Flanagan EFTA_R1_02173658 EFTA02718803 (Bloomberg) -- Avalanche=Biotech drops 14% in pre-mkt trading after announcing post-mkt yday plans =o scrap a planned Phase 2b trial and instead initiate added

gan in New York at +1.212-617-89=9 or cflanaganl@bloomberg=net <mailto:[email protected]> To contact the editors responsible for this story: Arie Shapira at +1-212-617-1488 or ashapira3@bloom berg. net <mailto:ashapi [email protected]> Cristin Flanagan 2 EFTA_R1_02173659 EFTA02718804